Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 350

1.

Current Controversies in Chronic Obstructive Pulmonary Disease: A Report from the GOLD Scientific Committee.

Criner GJ, Martinez FJ, Aaron S, Agusti A, Anzueto A, Bafadhel M, Barnes PJ, Bourbeau J, Chen R, Ewig J, Fabbri LM, Frith P, Halpin DMG, Han M, Montes de Oca M, Nishimura M, O'Donnell D, Papi A, Pavord I, Roche N, Rodriguez-Roisin R, Salvi S, Singh D, Sin DD, Stockley R, López Varela MV, Vestbo J, Vogelmeier CF, Washko G, Wedzicha JA, Celli BR.

Ann Am Thorac Soc. 2018 Nov 14. doi: 10.1513/AnnalsATS.201808-557PS. [Epub ahead of print] No abstract available.

PMID:
30427736
2.

Long-term efficacy and effectiveness of a behavioural and community-based exercise intervention (Urban Training) to increase physical activity in patients with COPD: a randomised controlled trial.

Arbillaga-Etxarri A, Gimeno-Santos E, Barberan-Garcia A, Balcells E, Benet M, Borrell E, Celorrio N, Delgado A, Jané C, Marin A, Martín-Cantera C, Monteagudo M, Montellà N, Muñoz L, Ortega P, Rodríguez DA, Rodríguez-Roisin R, Simonet P, Torán-Monserrat P, Torrent-Pallicer J, Vall-Casas P, Vilaró J, Garcia-Aymerich J.

Eur Respir J. 2018 Oct 18;52(4). pii: 1800063. doi: 10.1183/13993003.00063-2018. Print 2018 Oct.

3.

The dyspnoea-inactivity vicious circle in COPD: development and external validation of a conceptual model.

Ramon MA, Ter Riet G, Carsin AE, Gimeno-Santos E, Agustí A, Antó JM, Donaire-Gonzalez D, Ferrer J, Rodríguez E, Rodriguez-Roisin R, Puhan MA, Garcia-Aymerich J; and the PAC-COPD Study Group.

Eur Respir J. 2018 Sep 15;52(3). pii: 1800079. doi: 10.1183/13993003.00079-2018. Print 2018 Sep.

PMID:
30072504
4.

Precision medicine in COPD exacerbations.

Agusti A, Faner R, Celli B, Rodriguez-Roisin R.

Lancet Respir Med. 2018 Sep;6(9):657-659. doi: 10.1016/S2213-2600(18)30296-0. Epub 2018 Jul 18. No abstract available.

PMID:
30029970
5.

Hepatopulmonary Disorders: Gas Exchange and Vascular Manifestations in Chronic Liver Disease.

Rodríguez-Roisin R, Krowka MJ, Agustí A.

Compr Physiol. 2018 Mar 25;8(2):711-729. doi: 10.1002/cphy.c170020.

PMID:
29687908
6.

Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients with Moderate-to-Severe Asthma.

Papi A, Ryan D, Soriano JB, Chrystyn H, Bjermer L, Rodríguez-Roisin R, Dolovich MB, Harris M, Wood L, Batsiou M, Thornhill SI, Price DB.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):1989-1998.e3. doi: 10.1016/j.jaip.2018.03.008. Epub 2018 Apr 5.

PMID:
29627457
7.

Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD.

Ferguson GT, Rodriguez-Roisin R, Reisner C, Maes A, Siddiqui S, Martin UJ.

Int J Chron Obstruct Pulmon Dis. 2018 Mar 21;13:945-953. doi: 10.2147/COPD.S154988. eCollection 2018.

8.

The EASI model: A first integrative computational approximation to the natural history of COPD.

Agustí A, Compte A, Faner R, Garcia-Aymerich J, Noell G, Cosio BG, Rodriguez-Roisin R, Celli B, Anto JM.

PLoS One. 2017 Oct 10;12(10):e0185502. doi: 10.1371/journal.pone.0185502. eCollection 2017.

9.

Multi-level differential network analysis of COPD exacerbations.

Noell G, Cosío BG, Faner R, Monsó E, Peces-Barba G, de Diego A, Esteban C, Gea J, Rodriguez-Roisin R, Garcia-Nuñez M, Pozo-Rodriguez F, Kalko SG, Agustí A.

Eur Respir J. 2017 Sep 27;50(3). pii: 1700075. doi: 10.1183/13993003.00075-2017. Print 2017 Sep.

PMID:
28954781
10.

Corrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD" [Respir. Med. 120 November 2016 16-24].

Tashkin DP, Martinez FJ, Rodriguez-Roisin R, Fogarty C, Gotfried M, Denenberg M, Gottschlich G, Donohue JF, Orevillo C, Darken P, St Rose E, Strom S, Fischer T, Golden M, Reisner C.

Respir Med. 2017 Aug;129:164. doi: 10.1016/j.rmed.2017.06.011. Epub 2017 Jun 30. No abstract available.

11.

Global Initiative for Chronic Obstructive Lung Disease (GOLD) 20th Anniversary: a brief history of time.

Rodriguez-Roisin R, Rabe KF, Vestbo J, Vogelmeier C, Agustí A; all previous and current members of the Science Committee and the Board of Directors of GOLD (goldcopd.org/committees/).

Eur Respir J. 2017 Jul 5;50(1). pii: 1700671. doi: 10.1183/13993003.00671-2017. Print 2017 Jul. No abstract available.

PMID:
28679615
12.

Erratum to "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary" [Arch Bronconeumol. 2017;53:128-49].

Vogelmeier CF, Criner GJ, Martínez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DMG, Varela MVL, Nishimura M, Roche N, Rodríguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A.

Arch Bronconeumol. 2017 Jul;53(7):411-412. doi: 10.1016/j.arbres.2017.06.001. English, Spanish. No abstract available.

13.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martínez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodríguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A.

Arch Bronconeumol. 2017 Mar;53(3):128-149. doi: 10.1016/j.arbres.2017.02.001. Epub 2017 Mar 6. English, Spanish. Erratum in: Arch Bronconeumol. 2017 Jul;53(7):411-412.

14.

Socio-environmental correlates of physical activity in patients with chronic obstructive pulmonary disease (COPD).

Arbillaga-Etxarri A, Gimeno-Santos E, Barberan-Garcia A, Benet M, Borrell E, Dadvand P, Foraster M, Marín A, Monteagudo M, Rodriguez-Roisin R, Vall-Casas P, Vilaró J, Garcia-Aymerich J; Urban Training Study Group.

Thorax. 2017 Sep;72(9):796-802. doi: 10.1136/thoraxjnl-2016-209209. Epub 2017 Mar 1.

15.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A.

Eur Respir J. 2017 Mar 6;49(3). pii: 1700214. doi: 10.1183/13993003.00214-2017. Print 2017 Mar. Erratum in: Eur Respir J. 2017 Jun 22;49(6):.

16.

Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A.

Respirology. 2017 Apr;22(3):575-601. doi: 10.1111/resp.13012. Epub 2017 Mar 7.

17.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A.

Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.

18.

The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes.

Bosnic-Anticevich S, Chrystyn H, Costello RW, Dolovich MB, Fletcher MJ, Lavorini F, Rodríguez-Roisin R, Ryan D, Wan Yau Ming S, Price DB.

Int J Chron Obstruct Pulmon Dis. 2016 Dec 21;12:59-71. doi: 10.2147/COPD.S117196. eCollection 2017.

19.

Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD.

Martinez FJ, Rabe KF, Ferguson GT, Fabbri LM, Rennard S, Feldman GJ, Sethi S, Spangenthal S, Gottschlich GM, Rodriguez-Roisin R, Arora S, Siler TM, Siddiqui S, Darken P, Fischer T, Maes A, Golden M, Orevillo C, Reisner C.

Chest. 2017 Feb;151(2):340-357. doi: 10.1016/j.chest.2016.11.028. Epub 2016 Dec 1.

20.

Incidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: Effect of drug, dose, and device.

Dekhuijzen PNR, Batsiou M, Bjermer L, Bosnic-Anticevich S, Chrystyn H, Papi A, Rodríguez-Roisin R, Fletcher M, Wood L, Cifra A, Soriano JB, Price DB.

Respir Med. 2016 Nov;120:54-63. doi: 10.1016/j.rmed.2016.09.015. Epub 2016 Sep 22.

21.

A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD.

Tashkin DP, Martinez FJ, Rodriguez-Roisin R, Fogarty C, Gotfried M, Denenberg M, Gottschlich G, Donohue JF, Orevillo C, Darken P, St Rose E, Strom S, Fischer T, Golden M, Reisner C.

Respir Med. 2016 Nov;120:16-24. doi: 10.1016/j.rmed.2016.09.012. Epub 2016 Sep 17. Erratum in: Respir Med. 2017 Aug;129:164.

22.

The inflammasome pathway in stable COPD and acute exacerbations.

Faner R, Sobradillo P, Noguera A, Gomez C, Cruz T, López-Giraldo A, Ballester E, Soler N, Arostegui JI, Pelegrín P, Rodriguez-Roisin R, Yagüe J, Cosio BG, Juan M, Agustí A.

ERJ Open Res. 2016 Jul 11;2(3). pii: 00002-2016. eCollection 2016 Jul.

23.

Chronic Respiratory Symptoms with Normal Spirometry. A Reliable Clinical Entity?

Rodriguez-Roisin R, Han MK, Vestbo J, Wedzicha JA, Woodruff PG, Martinez FJ.

Am J Respir Crit Care Med. 2017 Jan 1;195(1):17-22. doi: 10.1164/rccm.201607-1376PP. No abstract available.

24.

Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD.

Fabbri LM, Kerwin EM, Spangenthal S, Ferguson GT, Rodriguez-Roisin R, Pearle J, Sethi S, Orevillo C, Darken P, St Rose E, Fischer T, Golden M, Dwivedi S, Reisner C.

Respir Res. 2016 Sep 2;17(1):109. doi: 10.1186/s12931-016-0426-4.

25.

Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease.

Rodriguez-Roisin R, Tetzlaff K, Watz H, Wouters EF, Disse B, Finnigan H, Magnussen H, Calverley PM.

Int J Chron Obstruct Pulmon Dis. 2016 Aug 22;11:1973-81. doi: 10.2147/COPD.S106142. eCollection 2016.

26.

Oral Low-dose Theophylline on Top of Inhaled Fluticasone-Salmeterol Does Not Reduce Exacerbations in Patients With Severe COPD: A Pilot Clinical Trial.

Cosío BG, Shafiek H, Iglesias A, Yanez A, Córdova R, Palou A, Rodriguez-Roisin R, Peces-Barba G, Pascual S, Gea J, Sibila O, Barnes PJ, Agusti A.

Chest. 2016 Jul;150(1):123-30. doi: 10.1016/j.chest.2016.04.011. Epub 2016 Apr 21.

PMID:
27107490
27.

Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.

Watz H, Tetzlaff K, Wouters EF, Kirsten A, Magnussen H, Rodriguez-Roisin R, Vogelmeier C, Fabbri LM, Chanez P, Dahl R, Disse B, Finnigan H, Calverley PM.

Lancet Respir Med. 2016 May;4(5):390-8. doi: 10.1016/S2213-2600(16)00100-4. Epub 2016 Apr 7.

PMID:
27066739
28.

Lung Tissue Volume is Elevated in Obesity and Reduced by Bariatric Surgery.

Santos A, Rivas E, Rodríguez-Roisin R, Sánchez M, Ruiz-Cabello J, Arismendi E, Venegas JG.

Obes Surg. 2016 Oct;26(10):2475-82. doi: 10.1007/s11695-016-2137-9.

PMID:
27000884
29.
30.

Inflammatory bowel diseases, chronic liver diseases and the lung.

Rodriguez-Roisin R, Bartolome SD, Huchon G, Krowka MJ.

Eur Respir J. 2016 Feb;47(2):638-50. doi: 10.1183/13993003.00647-2015. Epub 2016 Jan 21. Review.

31.

Validation of Walking Trails for the Urban Training™ of Chronic Obstructive Pulmonary Disease Patients.

Arbillaga-Etxarri A, Torrent-Pallicer J, Gimeno-Santos E, Barberan-Garcia A, Delgado A, Balcells E, Rodríguez DA, Vilaró J, Vall-Casas P, Irurtia A, Rodriguez-Roisin R, Garcia-Aymerich J; Urban Training™ Study Group.

PLoS One. 2016 Jan 14;11(1):e0146705. doi: 10.1371/journal.pone.0146705. eCollection 2016.

32.

Network Analysis of Lung Transcriptomics Reveals a Distinct B-Cell Signature in Emphysema.

Faner R, Cruz T, Casserras T, López-Giraldo A, Noell G, Coca I, Tal-Singer R, Miller B, Rodriguez-Roisin R, Spira A, Kalko SG, Agustí A.

Am J Respir Crit Care Med. 2016 Jun 1;193(11):1242-53. doi: 10.1164/rccm.201507-1311OC.

PMID:
26735770
33.

Inspiratory capacity-to-total lung capacity ratio and dyspnoea predict exercise capacity decline in COPD.

Ramon MA, Ferrer J, Gimeno-Santos E, Donaire-Gonzalez D, Rodríguez E, Balcells E, de Batlle J, Benet M, Guerra S, Sauleda J, Ferrer A, Farrero E, Gea J, Barberà JA, Agustí A, Rodriguez-Roisin R, Antó JM, Garcia-Aymerich J; PAC-COPD Study Group.

Respirology. 2016 Apr;21(3):476-82. doi: 10.1111/resp.12723. Epub 2015 Dec 30.

34.

Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD.

Magnussen H, Tetzlaff K, Bateman ED, Watz H, Kirsten AM, Wouters EF, Disse B, Finnigan H, Rodriguez-Roisin R, Calverley PM.

Eur Respir J. 2016 Feb;47(2):651-4. doi: 10.1183/13993003.01644-2015. Epub 2015 Nov 19. No abstract available.

35.

Benefits of physical activity on COPD hospitalisation depend on intensity.

Donaire-Gonzalez D, Gimeno-Santos E, Balcells E, de Batlle J, Ramon MA, Rodriguez E, Farrero E, Benet M, Guerra S, Sauleda J, Ferrer A, Ferrer J, Barberà JA, Rodriguez-Roisin R, Gea J, Agustí A, Antó JM, Garcia-Aymerich J; PAC-COPD Study Group.

Eur Respir J. 2015 Nov;46(5):1281-9. doi: 10.1183/13993003.01699-2014. Epub 2015 Jul 23.

36.

Pulmonary hemodynamic profile in chronic obstructive pulmonary disease.

Portillo K, Torralba Y, Blanco I, Burgos F, Rodriguez-Roisin R, Rios J, Roca J, Barberà JA.

Int J Chron Obstruct Pulmon Dis. 2015 Jul 14;10:1313-20. doi: 10.2147/COPD.S78180. eCollection 2015. Erratum in: Int J Chron Obstruct Pulmon Dis. 2015;10:2377.

37.

Postural effects on pulmonary gas exchange abnormalities in severe obesity before and after bariatric surgery.

Rivas E, Arismendi E, Agustí A, Gistau C, Wagner PD, Rodriguez-Roisin R.

Minerva Anestesiol. 2016 Apr;82(4):403-10. Epub 2015 Jun 9.

38.

Effectiveness of community-based integrated care in frail COPD patients: a randomised controlled trial.

Hernández C, Alonso A, Garcia-Aymerich J, Serra I, Marti D, Rodriguez-Roisin R, Narsavage G, Carmen Gomez M, Roca J; NEXES consortium.

NPJ Prim Care Respir Med. 2015 Apr 9;25:15022. doi: 10.1038/npjpcrm.2015.22.

39.

Airway Hyperresponsiveness to Mannitol in Obesity Before and After Bariatric Surgery.

Arismendi E, Rivas E, Vidal J, Barreiro E, Torralba Y, Burgos F, Rodriguez-Roisin R.

Obes Surg. 2015 Sep;25(9):1666-71. doi: 10.1007/s11695-014-1564-8.

40.

Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation.

Balcells E, Gimeno-Santos E, de Batlle J, Ramon MA, Rodríguez E, Benet M, Farrero E, Ferrer A, Guerra S, Ferrer J, Sauleda J, Barberà JA, Agustí À, Rodriguez-Roisin R, Gea J, Antó JM, Garcia-Aymerich J; PAC-COPD Study Group.

BMC Pulm Med. 2015 Jan 17;15:4. doi: 10.1186/1471-2466-15-4.

41.

Inhaled corticosteroids withdrawal in severe patients with chronic obstructive pulmonary disease: a wisdom decision?

Rodriguez Roisin R, Arismendi E.

Arch Bronconeumol. 2015 Feb;51(2):57-58. doi: 10.1016/j.arbres.2014.11.003. Epub 2015 Jan 4. English, Spanish. No abstract available.

42.

Nonpulmonary influences on gas exchange.

Rodriguez-Roisin R.

Compr Physiol. 2014 Oct;4(4):1455-94. doi: 10.1002/cphy.c100001. Review.

PMID:
25428851
43.

Ventilation/Perfusion distribution abnormalities in morbidly obese subjects before and after bariatric surgery.

Rivas E, Arismendi E, Agustí A, Sanchez M, Delgado S, Gistau C, Wagner PD, Rodriguez-Roisin R.

Chest. 2015 Apr;147(4):1127-1134. doi: 10.1378/chest.14-1749.

PMID:
25317652
44.

The systemic inflammome of severe obesity before and after bariatric surgery.

Arismendi E, Rivas E, Agustí A, Ríos J, Barreiro E, Vidal J, Rodriguez-Roisin R.

PLoS One. 2014 Sep 19;9(9):e107859. doi: 10.1371/journal.pone.0107859. eCollection 2014.

45.

Withdrawal of inhaled glucocorticoids and exacerbations of COPD.

Magnussen H, Disse B, Rodriguez-Roisin R, Kirsten A, Watz H, Tetzlaff K, Towse L, Finnigan H, Dahl R, Decramer M, Chanez P, Wouters EF, Calverley PM; WISDOM Investigators.

N Engl J Med. 2014 Oct 2;371(14):1285-94. doi: 10.1056/NEJMoa1407154. Epub 2014 Sep 8.

46.

A simple rule to identify patients with chronic obstructive pulmonary disease who may need treatment reevaluation.

Sharafkhaneh A, Altan AE, Colice GL, Hanania NA, Donohue JF, Kurlander JL, Rodriguez-Roisin R, Altman PR.

Respir Med. 2014 Sep;108(9):1310-20. doi: 10.1016/j.rmed.2014.07.002. Epub 2014 Jul 14.

47.

Should we exercise caution with benzodiazepine use in patients with COPD?

Rodriguez-Roisin R, Garcia-Aymerich J.

Eur Respir J. 2014 Aug;44(2):284-6. doi: 10.1183/09031936.00071014. No abstract available.

48.

[Chronic obstructive pulmonary disease: The golden decade. Implications for the diagnosis, prevention and treatment of chronic obstructive pulmonary disease].

López-Giraldo A, Rodríguez-Roisin R, Agustí A.

Med Clin (Barc). 2015 Jun 8;144(11):507-13. doi: 10.1016/j.medcli.2014.03.009. Epub 2014 May 10. Review. Spanish.

PMID:
24820902
49.

Stimulation of soluble guanylate cyclase prevents cigarette smoke-induced pulmonary hypertension and emphysema.

Weissmann N, Lobo B, Pichl A, Parajuli N, Seimetz M, Puig-Pey R, Ferrer E, Peinado VI, Domínguez-Fandos D, Fysikopoulos A, Stasch JP, Ghofrani HA, Coll-Bonfill N, Frey R, Schermuly RT, García-Lucio J, Blanco I, Bednorz M, Tura-Ceide O, Tadele E, Brandes RP, Grimminger J, Klepetko W, Jaksch P, Rodriguez-Roisin R, Seeger W, Grimminger F, Barberà JA.

Am J Respir Crit Care Med. 2014 Jun 1;189(11):1359-73. doi: 10.1164/rccm.201311-2037OC.

PMID:
24738736
50.

Disease progression in young patients with COPD: rethinking the Fletcher and Peto model.

Sanchez-Salcedo P, Divo M, Casanova C, Pinto-Plata V, de-Torres JP, Cote C, Cabrera C, Zagaceta J, Rodriguez-Roisin R, Zulueta JJ, Marin JM, Celli B.

Eur Respir J. 2014 Aug;44(2):324-31. doi: 10.1183/09031936.00208613. Epub 2014 Apr 2.

Supplemental Content

Loading ...
Support Center